| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/21/2011 | US20110177077 Pax 5 monoclonal antibody |
| 07/21/2011 | US20110177076 Humanized anti-amyloid beta antibodies |
| 07/21/2011 | US20110177075 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 07/21/2011 | US20110177073 Recombinant production of mixtures of antibodies |
| 07/21/2011 | US20110177072 Methods of treating inflammation in neuronal tissue |
| 07/21/2011 | US20110177071 Immunosuppressive polypeptides and nucleic acids |
| 07/21/2011 | US20110177070 TGF-Beta Antagonist Multi-Target Binding Proteins |
| 07/21/2011 | US20110177069 Novel inducer of chondrocyte proliferation and differentiation |
| 07/21/2011 | US20110177068 Pharmaceutical preparation comprising an antibody against the egf receptor |
| 07/21/2011 | US20110177067 Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177065 Methods of treating/preventing inflammation using combination of il-1 antagonist and il-18 binding protein |
| 07/21/2011 | US20110177064 Compositions and Methods for Treatment of Ovarian Cancer |
| 07/21/2011 | US20110177063 Methods for treating colorectal cancer |
| 07/21/2011 | US20110177062 Methods for treating breast cancer |
| 07/21/2011 | US20110177061 Methods of treating and preventing neurological disorders using docosahexaenoic acid |
| 07/21/2011 | US20110177060 Iap bir domain binding compounds |
| 07/21/2011 | US20110177059 Psa and klk2 as therapeutic targets and molecules inhibiting psa and klk2 |
| 07/21/2011 | US20110177058 Methods and compositions for modulating hgf/met |
| 07/21/2011 | US20110177057 Pharmaceutical preparation and manufacturing method thereof |
| 07/21/2011 | US20110177029 O-linked glycosylation using n-acetylglucosaminyl transferases |
| 07/21/2011 | US20110177027 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha |
| 07/21/2011 | US20110177023 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 07/21/2011 | US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/21/2011 | US20110176994 Buoyant Polymer Particles for Delivery of Therapeutic Agents to the Central Nervous System |
| 07/21/2011 | CA2788096A1 Il-22-fc and hepcidin activity |
| 07/21/2011 | CA2787128A1 Antibody formulation and therapeutic regimens |
| 07/21/2011 | CA2786936A1 Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues |
| 07/21/2011 | CA2786935A1 Variants of group 6 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues |
| 07/21/2011 | CA2786745A1 Wnt-binding agents and uses thereof |
| 07/21/2011 | CA2786660A1 Liver targeting molecules |
| 07/21/2011 | CA2785970A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | CA2784033A1 A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection |
| 07/20/2011 | EP2345722A1 Mutations in the parkin gene, compositions, methods and uses |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345716A1 Recombinant influenza viruses for vaccines and gene therapy |
| 07/20/2011 | EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof |
| 07/20/2011 | EP2345672A1 Anti-glycated cd59 antibodies and uses thereof |
| 07/20/2011 | EP2345671A1 Optimized fc variants and methods for their generation |
| 07/20/2011 | EP2345670A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/20/2011 | EP2345665A2 Flavivirus NS1 subunit vaccine |
| 07/20/2011 | EP2345664A2 Replikin peptides and uses thereof |
| 07/20/2011 | EP2345425A2 Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs |
| 07/20/2011 | EP2345424A1 CD4-specific antibody TRX1 and uses therefor |
| 07/20/2011 | EP2345423A1 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
| 07/20/2011 | EP2345422A1 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 07/20/2011 | EP2345421A1 Epitope composition for sublingual or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin |
| 07/20/2011 | EP2345420A1 Use of a TH1 immune response inducing adjuvant for enhancing immune responses |
| 07/20/2011 | EP2345419A1 Mucosal vaccine using cationic nanogel |
| 07/20/2011 | EP2344647A1 Hepatitis c virus expressing reporter tagged ns5a protein |
| 07/20/2011 | EP2344634A1 Methods for cultivating cells, propagating and purifying viruses |
| 07/20/2011 | EP2344542A2 Tubercolosis vaccines targeted to cd40 |
| 07/20/2011 | EP2344541A2 Antibodies directed to cd105 and uses thereof |
| 07/20/2011 | EP2344538A2 Antibodies against il-25 |
| 07/20/2011 | EP2344537A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 07/20/2011 | EP2344536A1 Antibodies directed to dll4 and uses thereof |
| 07/20/2011 | EP2344535A1 Antibodies against sonic hedgehog homolog and uses thereof |
| 07/20/2011 | EP2344534A1 New hcv entry factor, occludin |
| 07/20/2011 | EP2344523A1 Combination gas vaccines and therapeutics |
| 07/20/2011 | EP2344522A1 Combination adjuvant formulation |
| 07/20/2011 | EP2344233A1 Methods for reducing viral load of hepatitus c virus in hemodialysis patients |
| 07/20/2011 | EP2344194A2 Pcsk9 antagonists |
| 07/20/2011 | EP2344193A1 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 07/20/2011 | EP2344192A2 Method of making a vaccine |
| 07/20/2011 | EP2344191A1 Human papillomavirus / li-key hybrids and methods of use |
| 07/20/2011 | EP2344190A2 New virulence factors of streptococcus pneumoniae |
| 07/20/2011 | EP2344189A2 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 07/20/2011 | EP2344188A1 Anthrax vaccine formulation and uses thereof |
| 07/20/2011 | EP2344187A1 Targeting of antigen presenting cells with immunonanotherapeutics |
| 07/20/2011 | EP2344186A1 IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN |
| 07/20/2011 | EP2344185A1 Adjuvant incorporation in immunonanotherapeutics |
| 07/20/2011 | EP2344184A2 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 07/20/2011 | EP2344177A1 Immunotherapy compositions for the treatment and prevention of amyloidosis |
| 07/20/2011 | EP2344161A1 Combinations of a liposomal water-soluble camptothecin with cetuximab or bevacizumab |
| 07/20/2011 | EP2344152A2 Oral vaccines for producing mucosal immunity |
| 07/20/2011 | EP2168581A9 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 07/20/2011 | EP1997511B1 Therapeutic agent for rheumatoid arthritis |
| 07/20/2011 | EP1896067B1 Vaccines for immunization against helicobacter |
| 07/20/2011 | EP1896065B1 Process for manufacturing vaccines |
| 07/20/2011 | EP1684869B1 Methods of therapy for b cell-related cancers |
| 07/20/2011 | EP1625164B1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 42-46 |
| 07/20/2011 | EP1545613B1 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 07/20/2011 | EP1373477B1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 07/20/2011 | EP1317279B1 Vaccine against streptococcus pneumoniae |
| 07/20/2011 | EP1214097B3 Nucleic acids encoding polyepitope polypeptides |
| 07/20/2011 | EP1181317B1 An integrin heterodimer and an alpha subunit thereof |
| 07/20/2011 | EP1157043B1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 07/20/2011 | EP1053256B1 Antibodies to death receptor 4 (dr4) and uses thereof |
| 07/20/2011 | CN102131931A Adaptive molecule for delivery of adenovirus vectors |
| 07/20/2011 | CN102131830A Chimeric respiratory syncytial virus polypeptide antigens |
| 07/20/2011 | CN102131828A Antibodies to human programmed death receptor pd-1 |
| 07/20/2011 | CN102131524A Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 07/20/2011 | CN102131523A Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 07/20/2011 | CN102131522A HIV combination vaccine and prime boost method |
| 07/20/2011 | CN102131521A Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor |
| 07/20/2011 | CN102131520A Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling |
| 07/20/2011 | CN102131519A Diagnostic antibody assay |
| 07/20/2011 | CN102127554A Japanese encephalitis particle vaccine and preparation method and application thereof |
| 07/20/2011 | CN102127533A Preparation method of recombinant porcine circovirus type 2 Cap antigen |